199 related articles for article (PubMed ID: 32648887)
1. MOF nanoparticles with encapsulated dihydroartemisinin as a controlled drug delivery system for enhanced cancer therapy and mechanism analysis.
Li Y; Song Y; Zhang W; Xu J; Hou J; Feng X; Zhu W
J Mater Chem B; 2020 Aug; 8(33):7382-7389. PubMed ID: 32648887
[TBL] [Abstract][Full Text] [Related]
2. Supramolecular hybrids of carbon dots and dihydroartemisinin for enhanced anticancer activity and mechanism analysis.
Li Y; Shi N; Zhang W; Zhang H; Song Y; Zhu W; Feng X
J Mater Chem B; 2020 Nov; 8(42):9777-9784. PubMed ID: 33026041
[TBL] [Abstract][Full Text] [Related]
3. Nanoscale Melittin@Zeolitic Imidazolate Frameworks for Enhanced Anticancer Activity and Mechanism Analysis.
Li Y; Xu N; Zhu W; Wang L; Liu B; Zhang J; Xie Z; Liu W
ACS Appl Mater Interfaces; 2018 Jul; 10(27):22974-22984. PubMed ID: 29920061
[TBL] [Abstract][Full Text] [Related]
4. Metal-organic framework-encapsulated dihydroartemisinin nanoparticles induces apoptotic cell death in ovarian cancer by blocking ROMO1-mediated ROS production.
Yan Y; Yang X; Han N; Liu Y; Liang Q; Li LG; Hu J; Li TF; Xu Z
J Nanobiotechnology; 2023 Jun; 21(1):204. PubMed ID: 37386404
[TBL] [Abstract][Full Text] [Related]
5. A redox-responsive dihydroartemisinin dimeric nanoprodrug for enhanced antitumor activity.
Li Y; Pei Q; Cui B; Zhang H; Han L; Li W; Zhu W; Feng X; Xie Z
J Nanobiotechnology; 2021 Dec; 19(1):441. PubMed ID: 34930288
[TBL] [Abstract][Full Text] [Related]
6. Ligand-Modified Erythrocyte Membrane-Cloaked Metal-Organic Framework Nanoparticles for Targeted Antitumor Therapy.
Lin Y; Zhong Y; Chen Y; Li L; Chen G; Zhang J; Li P; Zhou C; Sun Y; Ma Y; Xie Z; Liao Q
Mol Pharm; 2020 Sep; 17(9):3328-3341. PubMed ID: 32804508
[TBL] [Abstract][Full Text] [Related]
7. One-Step Synthesis of Nanoscale Zeolitic Imidazolate Frameworks with High Curcumin Loading for Treatment of Cervical Cancer.
Zheng M; Liu S; Guan X; Xie Z
ACS Appl Mater Interfaces; 2015 Oct; 7(40):22181-7. PubMed ID: 26403308
[TBL] [Abstract][Full Text] [Related]
8. Facile synthesis of a metal-organic framework nanocarrier for NIR imaging-guided photothermal therapy.
Li Y; Xu N; Zhou J; Zhu W; Li L; Dong M; Yu H; Wang L; Liu W; Xie Z
Biomater Sci; 2018 Oct; 6(11):2918-2924. PubMed ID: 30229770
[TBL] [Abstract][Full Text] [Related]
9. Biomimetic Nucleation of Metal-Organic Frameworks on Silk Fibroin Nanoparticles for Designing Core-Shell-Structured pH-Responsive Anticancer Drug Carriers.
Chen Y; Wu H; Yang T; Zhou G; Chen Y; Wang J; Mao C; Yang M
ACS Appl Mater Interfaces; 2021 Oct; 13(40):47371-47381. PubMed ID: 34582680
[TBL] [Abstract][Full Text] [Related]
10. FA-PEG decorated MOF nanoparticles as a targeted drug delivery system for controlled release of an autophagy inhibitor.
Shi Z; Chen X; Zhang L; Ding S; Wang X; Lei Q; Fang W
Biomater Sci; 2018 Sep; 6(10):2582-2590. PubMed ID: 30151542
[TBL] [Abstract][Full Text] [Related]
11. Self-assembly and self-delivery of the pure nanodrug dihydroartemisinin for tumor therapy and mechanism analysis.
Li Y; Zhang W; Shi N; Li W; Bi J; Feng X; Shi N; Zhu W; Xie Z
Biomater Sci; 2023 Mar; 11(7):2478-2485. PubMed ID: 36763165
[TBL] [Abstract][Full Text] [Related]
12. Programmed Release of Dihydroartemisinin for Synergistic Cancer Therapy Using a CaCO
Wan X; Zhong H; Pan W; Li Y; Chen Y; Li N; Tang B
Angew Chem Int Ed Engl; 2019 Oct; 58(40):14134-14139. PubMed ID: 31389105
[TBL] [Abstract][Full Text] [Related]
13. Dual-Modal Therapeutic Role of the Lactate Oxidase-Embedded Hierarchical Porous Zeolitic Imidazolate Framework as a Nanocatalyst for Effective Tumor Suppression.
Zhou X; Zhao W; Wang M; Zhang S; Li Y; Hu W; Ren L; Luo S; Chen Z
ACS Appl Mater Interfaces; 2020 Jul; 12(29):32278-32288. PubMed ID: 32580547
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Application of a pH-Responsive Functional Metal-Organic Framework: In Vitro Investigation for Delivery of Oridonin in Cancer Therapy.
Shen J; Gao F; Pan Q; Zong Z; Liang L
Molecules; 2024 Jun; 29(11):. PubMed ID: 38893518
[TBL] [Abstract][Full Text] [Related]
15. Microfluidics-Assisted Surface Trifunctionalization of a Zeolitic Imidazolate Framework Nanocarrier for Targeted and Controllable Multitherapies of Tumors.
Shen J; Ma M; Zhang H; Yu H; Xue F; Hao N; Chen H
ACS Appl Mater Interfaces; 2020 Oct; 12(41):45838-45849. PubMed ID: 32956582
[TBL] [Abstract][Full Text] [Related]
16. MOF Nanoparticles with Encapsulated Autophagy Inhibitor in Controlled Drug Delivery System for Antitumor.
Chen X; Tong R; Shi Z; Yang B; Liu H; Ding S; Wang X; Lei Q; Wu J; Fang W
ACS Appl Mater Interfaces; 2018 Jan; 10(3):2328-2337. PubMed ID: 29286625
[TBL] [Abstract][Full Text] [Related]
17. Facile preparation of metal-organic frameworks-based hydrophobic anticancer drug delivery nanoplatform for targeted and enhanced cancer treatment.
Dong K; Zhang Y; Zhang L; Wang Z; Ren J; Qu X
Talanta; 2019 Mar; 194():703-708. PubMed ID: 30609594
[TBL] [Abstract][Full Text] [Related]
18. Zeolitic Imidazolate Framework (ZIF-8) Decorated Iron Oxide Nanoparticles Loaded Doxorubicin Hydrochloride for Osteosarcoma Treatment - in vitro and in vivo Preclinical Studies.
Wu W; Yu X; Sun J; Han Y; Ma Y; Zhang G; Ma Q; Li Q; Xiang H
Int J Nanomedicine; 2023; 18():7985-7999. PubMed ID: 38164268
[TBL] [Abstract][Full Text] [Related]
19. Nano-Scaled Zeolitic Imidazole Framework-8 as an Efficient Carrier for the Intracellular Delivery of RNase A in Cancer Treatment.
Jia J; Zhang S; Wen K; Li Q
Int J Nanomedicine; 2019; 14():9971-9981. PubMed ID: 31908453
[TBL] [Abstract][Full Text] [Related]
20. Biomimetic ZIF-8 Nanoparticles: A Novel Approach for Biomimetic Drug Delivery Systems.
Wang Y; Zeng M; Fan T; Jia M; Yin R; Xue J; Xian L; Fan P; Zhan M
Int J Nanomedicine; 2024; 19():5523-5544. PubMed ID: 38882544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
